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Abstract. Arterial or venous thromboses are frequent clinical complications with the risk of fatal progression. Recent studies
suggest the disruption of angiogenesis in the course of thrombus resolution as the underlying pathomechanism.
Very similar to the situation in human patients, equine vessels have been described to be particularly susceptible to thrombosis.
In contrast to humans, equine donors are readily available to obtain organs and tissues for isolation of endothelial cells.
Objective of this study was to isolate equine endothelial cells and develop an angiogenesis assay from primary cultures.
Macrovascular endothelial cells were obtained from jugular veins and carotid arteries of nine horses, one of which suffered
from inflammatory processes. After enzymatic isolation, the cells were incubated in different selective primary media. Phenotypic
identification of endothelial cells was accomplished by morphology and positive staining to von Willebrand factor. The reliable,
inexpensive, and standardized combination of methods presented here resulted in pure endothelial cultures for angiogenesis
assays that can be used in any cell culture laboratory.
Inverted phase microscopy and life cell imaging was used to characterize the stages of the angiogenic cascade of the endothe-
lial cells. Life cell imaging gave new insights into the in vitro formation of capillary like structures including exocytosis of
microparticles from endothelial cells before integration into the three-dimensional structure. We hypothesize that a specific
population of endothelial cells showing a highly active migration pattern in life cell imaging might play a role in the resolution
of thrombosis.
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1. Introduction
An early diagnosis of arterial or venous circulation disorders is paramount, since thrombosis is a
frequently occurring clinical complication with an increased risk of heart and cerebrovascular disease
or even death [3, 23]. Various predisposing factors have been determined which trigger thrombosis
manifestation including age [3], acute and chronical inflammatory processes [12, 40], malignancies [21],
or hemorheological aspects, such as reduced plasma viscosity [6], repeated mechanical manipulations
of peripheral vein catheters (venous side), or chemical properties of applied drugs [57]. In veterinary
medicine, for different reasons thrombosis is seen less frequently than in human medicine, except for
equine patients. Similar to human patients, horses often display severe vascular complications in the
context of chronic inflammatory processes, especially after intravenous interventions [17, 32, 35]. In
fact, equine vessels have been described to be more susceptible to chemical or mechanical manipulation
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than those of other species resulting in a hypercoagulation state in vivo [e.g., 30]. However, horses have
not been considered as a model for human vasculature yet, even though, in contrast to human organs
and tissues, samples from healthy equine donors are readily available, and pure endothelial cell strains
derived from primary cell cultures can be established easily. It is well known that primary cell cultures
and cell lines derived from primary cultures at low passages have many advantages over conventional cell
lines, since they retain the closest similarity to phenotypic characteristics of endothelium in vivo [e.g.,
49, 61]. Cell strains derived from primary cell cultures of healthy humans are rare, because for a variety
of reasons it is difficult to gain access to organs and tissues for the isolation of endothelial cells.
Both in humans and equines, the pathohistological mechanism of thrombosis is initiated by mecha-
nically or chemically induced lesions of the vascular endothelium, which lines the inner surface of all
blood vessels. This is followed by adherence of platelets to the endothelial cells. Platelet adhesion causes
enhanced secretion of inflammatory factors, which leads to infiltration of leukocytes into the vessel wall.
Further recruitment of platelets at the site of the endothelial lesion and fibrin formation eventually result
in coagulation and thrombosis [1, 57].
It is well known that vascular endothelial cells play an important mediatory role in the coagulative
response to inflammation and thrombosis [53]. However, these cells also seem to participate in the
resolution of thrombosis by building vascular channels into the fibrin clots [60]. Recent studies showed
that thrombus resolution depends on endothelial cell differentiation and angiogenesis [2].
We hypothesize that the reason for deficient thrombolysis in the equine is ineffective angiogenesis due
to mechanical or chemical lesion of endothelial cells. Thus, objective of this study was to isolate equine
endothelial cells and develop an angiogenesis assay from primary cultures to demonstrate the assessment
of each step of vascular development in vitro. In order to analyze details of individual and collective
activities of vascular endothelial cells during angiogenic morphogenesis, living endothelial cells were
examined during in vitro angiogenesis by life cell imaging. This technique allows monitoring of cell
development over a long period of time, i.e. up to several weeks [e.g., 80], under constant environmental
conditions. In addition, the cells can be examined in detail by employing time lapse microscopy.
2. Material and methods
2.1. Sampling
Samples of vessels from eight clinically healthy horses and one horse with gonarthritis and tarsal
phlegmona on the hindlegs were obtained (Table 1) after the animals had been euthanized at the Institute
for Veterinary Anatomy (Freie Universita¨t Berlin) under veterinary control in accordance with all relevant
local animal welfare laws and regulations. Samples of the left and right carotid arteries (Arteria carotis
communis) and jugular veins (Vena jugularis externa) were harvested. In all horses, the left jugular vein
was used for administering agents for euthanasia following sedation and general anesthesia.
2.2. Histology of vessels
Isolation of endothelial cells was carried out using an enzyme solution as described below. In order
to ensure that only endothelial cells had been harvested, samples of each vessel were prepared for light
microscopy before and after enzyme treatment. Samples were fixed in 4% buffered formalin for 24 hours,
dehydrated in an ascending series of alcohol and embedded in paraffin. Subsequently, slides of 4–6m
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Table 1
List of horses the samples were obtained from
Gender Age [yrs] Breed Samples
horse 1 ♂ 7 pony A. carotis communis sinistra
horse 2 ♂ 0.75 warmblood A. carotis communis sinistra
horse 3 ♀ 20 pony A. carotis communis sinistra
horse 4 ♂castrated 23 warmblood A. carotis communis sinistra/dextra
V. jugularis externa sinistra/dextra
horse 5 ♀ 13 pony A. carotis communis sinistra/dextra
V. jugularis externa sinistra/dextra
horse 6 ♂ 12 pony A. carotis communis sinistra/dextra
V. jugularis externa sinistra/dextra
horse 7 ♂ 18 pony A. carotis communis sinistra/dextra
V. jugularis externa sinistra/dextra
horse 8 ♂ 3.5 pony A. carotis communis sinistra
horse 9 ♂castrated 17 pony A. carotis communis sinistra/dextra
V. jugularis externa sinistra/dextra
were cut using a SM200R microtome (Leica, Wetzlar, Germany) followed by Weigert’s Resorcin-Fuchsin
staining as described elsewhere [71].
2.3. Isolation of endothelial cells
Samples of the vessels of 5 cm length were obtained antiseptically. After carefully cleaning the outside
of the vessel with 70% ethanol, samples were submersed and rinsed in a plastic tube containing 50 ml
of sterile PBS (phosphate buffered saline, 4◦C, Serva, Heidelberg, Germany) adapted with antibiotics
(10.000 U/ml penicillin, 10 mg/ml streptomycin, 5 mg/ml gentamicin) in order to remove the remaining
blood. Vessels were then transferred to a new tube with PBS/antibiotics, stored on ice and transported to
the laboratory.
All samples were processed in a laminar flow system under sterile conditions. After removal of fatty
and connective tissue, the vessel segments were filled with prewarmed (37◦C) collagenase solution and
incubated for 45 minutes until endothelial cells were detached. Then, the collagenase solution containing
cells was decanted into 15 ml tubes, gently mixed with 10 ml of PBS/antibiotics and centrifuged at 200× g
for five minutes at room temperature. The pellet was resuspended in 15 ml PBS/antibiotics and centrifuged
again. Next, the cells were resuspended in 3 ml primary growth medium (P0) and processed repeatedly
through a Sterican needle (Sterican, 0.6 × 30 mm, Braun, Melsungen, Germany) in order to separate
aggregated cell structures. Six-well plates were coated with 2 ml of autoclaved 1.5% porcine gelatin Type
A [Sigma-Aldrich, Taufkirchen, Germany] suspended in PBS at 37◦C for 30 minutes. Subsequently, wells
were loaded with 1.5 ml cell suspension per well and incubated at 37◦C with 5% CO2 concentration and
98% relative humidity after the fluid had been removed. This last step of isolation was completed within
two hours after sampling from the animals. After another two hours the medium was changed, removing
most of the non-endothelial cells, which have less adhesion capacity than endothelial cells [38, 64].
When the cells had formed clonal islets of approximately 25 polygonal cells, they were scraped off
using a cell scraper. Subsequently, cells of one islet were centrifuged in PBS/antibiotics and the pellet was
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Table 2
Solutions used for cell culture
DMEM+ Culture medium 43.5 ml Dulbecco’s Modified Eagle Medium (DMEM containing 3.7 g/l NaHCO3;
4.5 g/l D-glucose; low endotoxin) (Biochrom AG, Berlin)
5 ml FBS (Gibco/life technologies, Darmstadt) or FHS (biowest, Nuaille´, France)
0.5 ml L-glutamin (200 mM) (Sigma-Aldrich, Taufkirchen)
0.5 ml gentamicin (5 mg/ml) (PromoCell GmbH, Heidelberg)
0.5 ml penicillin/streptomycin (10.000 U/ml/10 mg/ml) (Sigma-Aldrich,
Taufkirchen)
P0 Primary medium 32.5 ml DMEM+
Conventional serum: 5 ml FBS (Gibco/life technologies, Darmstadt)
Species-specific serum: FHS (biowest, Nuaille´, France)
1 ml ECGS (endothelial cell growth supplement from bovine neural tissue)
(Sigma-Aldrich, Taufkirchen)
0.5 ml penicillin/streptomycin (10.000 U/ml/10 mg/ml) (Sigma-Aldrich,
Taufkirchen)
0.5 ml heparin sodium salt from porcine intestinal mucosa (Sigma-Aldrich,
Taufkirchen)
0.5 ml BME vitamin (100×) (Sigma-Aldrich, Taufkirchen)
Enzyme solution for isolation of cells 25 mg Collagenase II from Clostridium histolyticum (≥125 CDU/mg)
(Sigma-Aldrich, Taufkirchen)
25 mg Collagenase IV from Clostridium histolyticum (≥125 CDU/mg)
(Sigma-Aldrich, Taufkirchen)
9.8 ml DMEM (Biochrom AG, Berlin)
100l NU-Serum IV Serum Replacements (BD Biosciences, Heidelberg)
100l DNase solution (20.000 U/ml in H2O) (Sigma-Aldrich, Taufkirchen)
S180 conditioned medium S180 mouse sarcoma cells were cultured in DMEM+medium. Used
cell-conditioned medium was removed, collected and filtrated using sterile
syringe filters with pore size 22m (Techno Plastic Products AG, Trasadingen
Switzerland)
covered with 0.05% trypsin-EDTA (37◦C) (Gibco/life technologies, Darmstadt, Germany). Alternately,
several islands (up to 4) were pooled. After 2-3 minutes, DMEM+ was added to stop trypsin action. The
cells were centrifuged, and the pellet was resuspended in 500l P0 medium. From these primary cells
(passage 1), primary cell culture lines were established on gelatin coated 24-well plates. Medium was
renewed every three to four days. For detailed information on chemicals and solutions see Table 2.
After cells of passage 1 had reached the subconfluent stage, they were trypsinized (0.05% trypsin-
EDTA, 37◦C) and resuspended in P0. After expanding the cultures by another passaging, cells were
processed in the third passage for all further examinations including:
1. identification and characterization by phase contrast and transmission electron microscopy
2. identification via immunocytochemistry
3. monitoring vascular development by phase contrast microscopy and life cell imaging
4. analysis of growth in different culture media
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2.4. Phenotypic characterization and identiﬁcation of cells
Phenotype of the equine endothelial cells was examined by inverted phase microscopy (Zeiss Axiovert
25) and identified by staining with an antibody to von Willebrand Factor (vWF, Factor VIII) [42, 45,
55]. Transmission electron microscopy was used to examine ultrastructure and demonstrate presence of
endothelial marker organelles, i.e. Weibel Palade bodies [87, 88].
For antibody staining, 3.000 cells of passage 3 were seeded on 96-well plates and kept in culture for
defined time intervals. Subsequently, the cells were fixed in a 1:1 ice-cold acetone and methanol mixture
and rinsed with distilled water and PBS. This was followed by treatment with blocking buffer containing
1.5% H202, 0.1% saponine, and 1% bovine serum albumin (BSA) in PBS. After washing with PBS
and 3% BSA, cells were processed with polyclonal rabbit anti-human vWF (Dako GmbH, Hamburg) as
primary antibody with cross reactivity to equine cells. Cross reactivity is based on the conserved structure
of equine and human genes with an identity of 87% of the nucleotid sequence coding for vWF (PubMed
Basic Local Alignment Search Tool).
Buffer and buffered rabbit IgG fraction (Dako GmbH, Hamburg) were used as negative controls with
protein concentrations used corresponding to antibody concentrations (155g/ml).
For transmission electron microscopy 10.000 cells were seeded on a 3470 polyester membrane (Corn-
ing, Wiesbaden, Germany) and cultured for 15 days. Culture medium was removed and substituted by
PBS, followed by cacodylate buffer (0.1 M, pH 7.2) and Karnovsky’s fixative (Merck Eurolab, Darm-
stadt, Germany). After 4 hours of refrigeration at 4◦C, the cells were rinsed with cacodylate buffer and
contrasted with cacodylate-buffered osmium tetroxide (1%) for 2 hours at 4◦C. Subsequently, the cells
were dehydrated and embedded in epon via propylene oxide (Serva Electrophoresis, Marburg, Germany).
Semi-thin sections (0.8m) were evaluated to establish the appropriate specimen for ultra-thin section-
ing (Ultracut, Reichert-Jung, Vienna, Austria). Slides of 70 nm were cut and absorbed to nickel grids,
contrasted with lead citrate and uranyl acetate, and examined using an EM10CR electron microscope
(Zeiss, Jena, Germany).
2.5. Monitoring of vascular development of cells in vitro
20.000 endothelial cells of passage 3 were seeded on 24-well plates. Over a time period of eight weeks,
these cells were monitored and photographed at regular intervals to document stages of angiogenesis
using a phase contrast microscope. Digital pictures of randomly chosen areas were taken with a video
camera (Inteq 00061; Inteq, Berlin, Germany) using the image editing system Axiovision (Verison 3.0;
Zeiss, Jena, Germany). Visual fields were standardized by taking pictures at the same magnification (100
x) and the same area (691200m2).
In addition, endothelial cells were monitored using an inverted Olympus IX 81 life cell imaging
microscope (Olympus, Hamburg, Germany) with integrated climatization control. Cells were investi-
gated in their native state without immunofluorescence labeling. The culture dishes were placed in a
temperature-controlled chamber at 37◦C with 5% CO2 and about 50% humidity to prevent evaporation
of the culture medium. The microscope was equipped with a monochrome cooled XM10 CCD camera
(Olympus, Hamburg, Germany). Olympus Cell R software version 3.1 was used for image-acquisition
(Olympus, Hamburg, Germany). Images were obtained using an Olympus UPLFLN phase-contrast with
a 20× NA 0.45 objective. Original images were 16 bit grey scale with a resolution of 1.376 × 1.032
pixels.
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20.000 cells of passage 3 were seeded on 24-well plates. Endothelial cells were examined at defined
intervals shown as a series combination of different focal planes (z-stack), and recorded in time-lapse
mode. Different projections were used in a series to produce a single three-dimensional image.
Moreover, time-lapse live imaging of the cells was started on the 28th culturing day of the assay.
Long-time sequences over 44 hours of these cells were documented at one frame every six minutes and
also recorded in time-lapse mode. The medium was changed every three to four days until termination
of the assay.
2.6. Documentation of cellular proliferation and vascular development in different culture media
To find the optimal medium for angiogenesis and capillary formation in vitro, cells were cultivated
in different media containing conventional fetal bovine serum (FBS) and species-specific equine serum
(fetal horse serum, FHS), either in S180-conditioned or unconditioned medium. For detailed information
on chemicals and solutions see Table 2.
3. Results
3.1. Histology
Weigert’s Resorcin-Fuchsin staining of the vessel samples prior to and after collagenase treatment
revealed that endothelial cells were removed evenly from the tunica intima of the vessels (Fig. 1). Even
though the lamina elastica interna was clearly visible, especially in the sampled arteries, indicating an
intact muscular layer, it cannot be ruled out that single cells other than endothelial cells, such as fibrocytes
of the subendothelial layer or smooth muscle cells of the media, were harvested.
A B
Fig. 1. Arteria carotis communis, Weigert’s Resorcin-Fuchsin staining; A: cell nuclei of intact endothelium (arrows) prior to
collagenase treatment; B: endothelium removed after collagenase treatment, lamina elastic interna (arrow); light microscopy,
original magnification 400×.
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3.2. Primary cultures
After two hours 50% of the cells of the primary cultures, seeded on 6-well plates in a density of
approximately 4 × 104 cells, were adherent to the bottom of the culture plate (Fig. 2).
At this point in time, the primary cell cultures represented mixed populations of different cell species.
Most of the cells were of polygonal shape. However, individual spindle shaped cells (which probably
correspond to fibroblasts or smooth muscle cells) were observed (Fig. 3).
These cells were further separated from the polygonal ones at first passaging, when clonal islets of
approximately 25 polygonal cells exclusively were carefully scraped off and seeded separately or pooled
in a new gelatinized 24-well plate. These cells proliferated and formed colonies of 25–200 cells as seen
in Fig. 4.
Fig. 2. Phase contrast microscopy of primary equine endothelial cells in vitro. After two hours in vitro, 50 % of the cells were
adherent at the bottom of the culture plate, original magnification 100×.
Fig. 3. Phase contrast microscopy of primary equine endothelial cells in vitro. Primary cell cultures with clonal islets; polygonal
and spindle shaped cells are visible, original magnification 100×.
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Fig. 4. Passage 2, phase contrast microscopy of endothelial cells derived from primary equine cells in vitro, original magnification
100×.
3.3. Identiﬁcation and characterization of equine endothelial cells
In addition to the identification of cells via immunolabelling of endothelial markers and demonstration
of endothelial marker organelles, the phenotype of equine endothelial cells was confirmed via phase
contrast microscope in vitro. Cells contained a single nucleus, often with two nucleoli; surrounding cyto-
plasm appeared granular, cell membranes were clearly visible. Whereas the endothelial cells developed
up to 4 fine protrusions in the subconfluent monolayer, they became roundish without projections upon
confluency. In the confluent monolayer the cultures displayed the characteristic endothelial “cobblestone
pattern”. This also marked the start of the angiogenic cascade in the cultures. The population doubling
time was ca. 48 h.
3.4. Ultrastructural characterization
In most cells, the shape of nuclei was elongated and regular (Fig. 5). Up to nine electron dense roundish
to rod-shaped tubular bodies were found to be located in the cytoplasm close to the outer cell membrane
in one section of a cell (Fig. 6). These endothelial specific organelles, so-called Weibel-Palade bodies,
were observed in many cells.
The endothelial cells also displayed certain other organelles, such as rough endoplasmatic reticulum and
mitochondria of the crista type. Microvilli were present on the cellular surfaces. Intercellular contacts were
formed by interdigitations of the outer cell membranes. Fibrillar material was located in the extracellular
space and between the cellular membranes.
3.5. Expression of the endothelial cell speciﬁc vWF
Identification of the endothelial cells was also performed by immuno-localization of vWF. All cells
of passage 3 cultures stained strongly positive for anti-vWF. Cells displayed distinct granular staining
across their cytoplasma (Fig. 7). Until day 10 in vitro, the cell nucleus appeared to be stained stronger
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Fig. 5. Ultrastructure of primary equine endothelial cells. Regularly shaped nucleus (N) and numerous organelles, especially
mitochondria (M), transmission electron microscopy, original magnification 25.000×.
Fig. 6. Ultrastructure of primary equine endothelial cells. Weibel-Palade bodies (arrows) are located in the cytoplasm close to
the outer cell membrane, transmission electron microscopy, original magnification 31.500×.
than the cytoplasma. After 15 days, staining for vWF antibody of the endothelial cell cultures became
weaker, but was still visible.
3.6. Staging of development and morphology of capillary-like structures of equine endothelial cells
in vitro
In subsequent analyses, only cells that were positive for endothelial markers were included. Upon
seeding, cells of passage 3 proliferated and formed roundish colonies of 10 to 20 polygonal cells. While
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A B
Fig. 7. Phase contrast microscopy of primary equine endothelial cells in vitro, light microscopy, original magnification 200×.
A: all cells of the passage 3 cultures stained strongly positive for anti-von Willebrand factor (vWF); B: negative control.
continuously proliferating, new cells at the edge of the colonies became longish and arranged linearly
side by side. Thus, the shape of growing colonies changed and became elongated. Cells located at the tips
of these elongated cellular islands developed cellular protrusions and pseudopodia and finally connected
with similar cells of neighboring islands. Upon reaching confluency, cells regained their polygonal shape
and a homogenous cobblestone-like monolayer covered 100% of the culture dish (stage 1 of the angiogenic
cascade, Fig. 8A).
Upon confluency, sprouting was observed in certain areas of the culture dish. Single cells of the mono-
layer developed protrusions of 1–2m in size superimposing the monolayer. During further development,
these cells proliferated and arranged themselves linearly side by-side, followed by the formation of planar,
circular structures a few days later (stage 2 of the angiogenic cascade, Fig. 8B).
The circular cell structures connected and formed planar structures. Eventually, a distinct network
consisting of single cell strands was present (stage 3 of the angiogenic cascade in vitro, Fig. 8C). A
confluent monolayer still covered the culture dish.
In the following weeks, the linear endothelial strands transformed into three-dimensional capillary-like
structures. At the same time, cell free areas appeared in the monolayer. In part, the capillary-like structures
detached from the bottom of the culture well. The more cells were integrated into the cell-strands the
more cell-free areas were detected. New cells appeared to integrate via pseudopodia formation into the
network, which was attached to the bottom of the culture plate only in a few places. The cell-free areas of
the network continued to increase in diameter by integration of an increasing number of cells. Finally, the
endothelial cells displayed a three-dimensional configuration with a web-like pattern. Only about 20%
of the endothelial cells remained on the bottom of the culture dish (stage 4 of the angiogenic cascade,
Fig. 8D).
3.7. Life cell imaging
Life cell imaging allowed tracking of individual endothelial cells during in vitro angiogenesis.
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Fig. 8. Phase contrast microscopy of primary equine endothelial cells in vitro monitoring the angiogenesis cascade, original
magnification 100×. (A) Stage 1, confluent monolayer. (B) Stage 2 of angiogenic cascade, individual cells of the monolayer
developed protrusions; after linear side by-side arrangement, the cells formed planar, circular structures. (C) Stage 3, pla-
nar capillary-like structures and networking of single cell strands. (D) Stage 4, endothelial cells display a three-dimensional
configuration.
Stage 1 of the angiogenesis cascade in vitro: Following mitotic proliferation cells formed a colony of
ca. 10–20 cells. Before a confluent monolayer was formed, individual cells at the edges of the colonies
developed protrusions of 1–2m in length. Subsequently, these cells started mitosis, i.e. they rounded
up and lost adhesion to the colony. After the two daughter cells had been generated, they immediately
re-developed cellular protrusions. With these, they contacted neighboring cells and either integrated
themselves into the colony of origin or migrated towards neighboring colonies. Recurring contact to
neighboring cells, particularly to those from different colonies, resulted in immediate mitosis. Frequently
it could be observed that specific cells at the tip of the colonies detached themselves reversed their forward
movement, and migrated back into the colony. Then, these cells moved through the whole length of the
colony, thus passing a phalanx of 10 and more cells on each side. Certain tip cells returned to the cell
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Fig. 9. Life cell imaging: sequence of primary equine endothelial cells in vitro after 28 days in culture; original magnification
200×. (A) Single elongated cell (from left) contacts existing cellular strand (0 minutes). (B) The formerly elongated cell changes
to a roundish shape upon contact (after 25 minutes). (C) At the point of intercellular contact microparticles are released into the
extracellular space. The released material consists of a group of vesicles of different size, floating into the culture medium (after
216 minutes). (D) Finally, the cell is integrated into the three-dimensional capillary like network (after 1782 min).
cluster, moved through it, and then once again led the formation of another new vascular sprout. Gradually
a homogenous monolayer of polygonal to longish cells was formed.
Stage 3 and 4 of the angiogenesis cascade in vitro (life cell monitoring started on the 28th culturing day):
In this monolayer, certain cells became prominent and formed cellular strands by distinct elongation and
linear arrangement, while most of the other cells still were in a polygonal state. Eventually, the single cell
strands developed into two stranded structures with translucent extracellular material between and around
them. In certain areas of the monolayer these elongated cells developed fine protrusions superimposing
the monolayer (Fig. 9A). Cells from the bottom of the culture plate integrated themselves into the cellular
strands (after 2.5 hours, Fig. 9B). These cells were either located in the monolayer next to an existing
strand or they migrated up to several micrometers towards the strand by pseudopodia. Upon contact
with the strands, they regained a polygonal to roundish form. During this process, cellular material
was released into the extracellular space (after 216, Fig. 9C). This material consisted of microparticles.
Most of these were round vesicles of fairly homogenous size, only a few resembled irregularly shaped
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cellular fragments. The extracellular material was suspended in the culture medium. The more cells were
integrated into the cell-strands, the fewer cells remained adhering to the culture dish until finally most
of the cells were forming a three-dimensional capillary like network (after 29.7 hours = 1782 minutes,
Fig. 9D).
3.8. Documentation of cellular proliferation and vascular development in different media
Cells were cultivated in media supplied with a) conventional fetal bovine serum (FBS) plus S180-
or without S180-conditioned medium or b) species-specific equine serum (fetal horse serum, FHS) with
S180- or without S180-conditioned medium. Cells grew readily in either medium, with the cells cultivated
with unconditioned FHS forming a confluent monolayer around two days later than the other cultures.
3.9. Cells from horse with inﬂammatory processes
The sample obtained from the nine-month old horse, which suffered from inflammatory processes prior
to euthanasia (inflammation of the left stifle, phlegmona of the right tarsus) displayed the poorest prolif-
eration rate. At that point in time when the primary cultures from clinically healthy horses represented a
subconfluent monolayer with thousands of cells, only around 50 cells were proliferating in this sample.
After seven days, these cells stopped proliferating.
4. Discussion
Objective of this study was to develop an in vitro model that allows for evaluating morphology and
angiogenesis of primary equine endothelial cell line cultures. Thus, equine endothelial cells from the
carotid artery and jugular vein were isolated, identified, cultivated in vitro, and the different stages of the
angiogenesis cascade were characterized in these cell cultures including life cell technique. This study
presents the first in vitro angiogenesis assay of equine endothelial cells. In the past, equine endothelial
cells were isolated from the aorta [51, 82], pulmonary artery [51, 56, 82], umbilical vein [22], fatty
omentum [16], carotid artery [13, 37], or brain [37]. These cultures were used in studies focusing on
clinical aspects related to viral infections or endotoxemia without addressing the angiogenesis cascade.
4.1. Identiﬁcation and characterization of equine endothelial cells in vitro
The Achilles’ heel during the establishment of endothelial cell cultures is the contamination with
non-endothelial cells. Different methods are recommended to obtain pure cultures including antibody
supported sorting of cultures with fluorescence activated or magnetic bead cell sorting [15, 58]. In our
laboratory, endothelial cultures from micro- and macrovascular vessels of different species (bovine,
porcine, equine, murine, simian, human), developmental stages (fetal, neonatal, adult), or organs and
tissues (testes, ovary, corpus luteum, brain, heart, spleen, lung, skin, foreskin, limb, tumor) [e.g., 10, 11,
41, 47, 48, 64, 74, 77] have been established and different methods have been used including a FACS+
cell sorter. A reliable, inexpensive, and standardized combination of methods used in the present study
resulted in pure cultures of macrovascular endothelial cells, which can be established in any laboratory
with routine cell culture equipment.
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The experimental setup employed here was focused on using optimal coating of the culture dishes,
effective supplementation of the medium, separation of cells that displayed quick adherence, and analysis
of the cell morphology. Another focal point was the confirmation of cellular identity by immunolabelling
with the specific marker anti-vWF and ultrastructural demonstration of the presence of endothelial marker
organelles, i.e. Weibel Palade bodies.
In order to selectively support the growth of the endothelial cells, gelatin was used for coating the
culture dishes. Gelatin contains amino acids and proteins, similar to those of the basement membrane,
which corresponds to the natural environment of endothelial cells [5]. In our experience, gelatin coating
is particularly favorable, since endothelial cells immediately adhere to it and thus to the bottom of the
culture wells. Gelatin has been used successfully since the onset of endothelial cell isolation [50, 78, 86].
In contrast to Matrigel, which is frequently used to coat culture dishes in order to activate endothelial
angiogenesis, gelatin is derived from clinically healthy animals, whereas Matrigel is the product of
tumor cells [e.g., 44]. Other authors describe the usage of different substrates such as purified collagen
[61] or fibronectin [24] for coating. Relou et al. [67] did not find significant changes in the growth
of human umbilical vein endothelial cells after coating the culture dishes with gelatin, fibronectin, or
collagen.
Proliferation of endothelial cells is supported selectively by incubation in primary medium, which
contains a combination of growth factors for endothelial cells supporting their proliferation from day 1.
In our study, P0 medium containing mouse S180 sarcoma cells conditioned medium was used, which has
been reported to upregulate endothelial cell expression of basic fibroblast growth factor [75]. Contrary
to our expectations, media supplemented with fetal horse serum (FHS) did not increase endothelial
proliferation. Both FHS and FBS have been described as suitable supplement to culture medium for equine
endothelial cells [51]. However, for different applications species-specific serum has been recommended
For example, Zakrzewski et al. [90] described that species-specific serum allowed for better results than
FBS when cultivating porcine intestinal cells. Our results are corroborated by Mitchell et al. [59] who in
1969 had already described the superiority of FBS for the selection of cell variants and as best adapted
for continuous cell growth in vitro.
The endothelial cells were selected on the basis of their distinct adhesiveness to the gelatin precoated
culture plates as compared to other cells. In contrast to non-endothelial cells, endothelial cells show an
extraordinary adherence to the coating of the culture dish [e.g., 78]. Thus, slowly adhesive cells were
washed away with the supernatant on the first rinsing two hours after the primary seeding. In our study,
only the cells adhering quickly, i.e. within 2 hours, were expanded and used for further processing. Navone
et al. [61] also used this method successfully to identify and characterize endothelial isolations.
Contamination with non-endothelial cells is a common problem in primary endothelial cell cultures.
In our experience, rapid proliferation rate with multilayered growth points towards the presence of non-
endothelial cells. Nevertheless, identification of the cells on a morphological basis and by light microscopy
only is not feasible. For this reason, endothelial specific markers are necessary to identify these cells.
Specific endothelial markers include vWF and the ultrastructural detection of Weibel Palade bodies
[87, 88]. vWF is stored within Weibel-Palade bodies (WPBs), organelles that appear exclusively in
endothelial cells. In this study, 100% of the cells of passage 3 were positive for vWF labeling, which
strongly corroborates their endothelial specific character. Labeling became less distinct with extended
time in culture, but still was clearly present. Fading and even loss of labeling for vWF has been described
for other endothelial cultures including equine endothelial cells and is a frequent effect of long term
culturing, indicating a progressive loss of the endothelial phenotype after prolonged time of culture
and increased passages [13, 56]. It is a well-known fact that cells in vitro both gain and lose attributes
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found in vivo. Since it is generally not feasible to use truly primary (not passaged) endothelial cells in
angiogenesis assays [6], cell lines derived from primary cultures as presented here may be optimal for
the characterization of angiogenesis.
In addition, endothelial nature of the isolated cells was confirmed by the presence of Weibel Palade
bodies. These organelles are elongated secretory organelles specific to endothelial cells contributing to
inflammation, angiogenesis, and tissue repair [83]. They have been described in most vertebrates including
humans [e.g., 43, 87], pigs [34, 72], rats [18], rabbits [14, 68], pigeons [65], fish [89], and amphibians
[79].
4.2. Development and morphology of capillary-like structures of equine endothelial cells in vitro
In general, there are two pathways leading to the formation of blood vessels: vasculogenesis and
angiogenesis [e.g., 62, 63, 69, 70]. Vasculogenesis corresponds to the de novo formation of primitive
vascular networks from endothelial progenitor cells, which differentiate into endothelial cells. In contrast,
angiogenesis refers to the sprouting and splitting of existing blood vessels by activation, proliferation,
and migration of endothelial cells. In vivo, this process is present in physiological, pathophysiological
or pathological processes and is induced by certain signal proteins, such as vascular endothelial growth
factors or fibroblast growth factors [e.g., 8, 28, 33, 81]. The angiogenic cascade of endothelial cells
in vitro has been classified and quantified for bovine [8, 9], human [55], and murine [55] endothelium
into the following stages: stage 0: proliferation of endothelial cells; stage 1: subconfluent to confluent
monolayer of endothelial cells; stage 2: linear and circular side by side arrangement of endothelial cells;
stage 3: formation of planar capillary-like structures with an internal lumen; stage 4: formation of a
three-dimensional network of capillary-like structure [55]. These stages of the angiogenic cascade could
clearly be identified in the equine cultures presented here and confirms the applicability of the cultures
in angiogenesis assays.
4.3. Life-cell imaging and tracking of individual cells in vitro
In addition to inverted light microscopy life cell imaging was used to characterize endothelial prolif-
eration and in vitro angiogenesis. This allowed for tracking of living endothelial cells in the course of
time and the identification of different subpopulations of endothelial cells. To date only few studies are
available employing life cell imaging in angiogenesis research [e.g, 4, 54].
Sprouting of single cells out of the monolayer could be documented. These specialized endothelial cells
that lead the new sprout at the front are called tip cells [19]. Tip cells have been observed in various models
of sprouting angiogenesis [e.g., 31, 46]. Key features of the tip cell are their location at the forefront of
endothelial branches, numerous filopodia, the lack of lumen formation, and minimal proliferation [27].
Endothelial tip cells are selected from a quiescent vessel by stimulation due to angiogenic factors in the
course of vessel branching or pathological processes and are followed by stalk cells [20]. However, tip and
stalk cells change positions frequently during sprouting [e.g., 24, 46]. In this context, the following feature
observed here may be relevant: Certain tip cells reversed their forward movement, returned to the cell
cluster, moved through the whole length of the cluster, and then once again led the formation of another
new vascular sprout. This compares to the results of Li and Stuhlmann [54] who described that endothelial
cells moved backwards and forwards, and even overtook each other at the tip, displaying an unknown mode
of collective cell movement with dynamic ‘cell-mixing’. Thus, we assume that this specific and highly
migratory subpopulation of tip cells as seen in equine endothelial cultures may contribute in the resolution
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of thromboses by building vascular channels into fibrin clots. Their malfunction after mechanical or
chemical manipulation might be the reason for arterial or venous thrombosis and thrombophlebitis [2].
After single cell strands of equine endothelial cells had developed into two stranded structures, translu-
cent, extracellular material was found to be present between and around them resembling a basement
membrane. This corroborates the realistic nature of the equine angiogenesis model presented here.
Endothelial cells produce their extracellular matrix and basement membrane in vivo [39, 84]. Sacharidou
et al. [73] described that endothelial cells depend on vascular guidance tunnels, which are generated by
extracellular matrix. This eventually leads to vascular basement membrane matrix assembly, which in
turn is essential to tube maturation and stabilization in order to form capillary networks [25].
Equine endothelial cells released microparticles into the extracellular space. These are defined as
particles ranging from 100 nm to 1m in diameter. They are released from the plasma membrane of cells
by outward budding of membrane vesicles. Studies suggest that the release of microparticles is a highly
regulated process that occurs in a spectrum of cell types including endothelial cells. Microparticles have
been detected in many various biological fluids, including peripheral blood and urine [76].
Exocytosis of microparticles is an important step in a multitude of different cellular events such as
coagulation [29] or cytokine secretion [66]. Early on, Wagner & Robinson [85] showed three-dimensional
conformation and interaction of vesicles with the endothelial surface in endothelium of muscular tissue
by high-voltage electron miscroscopy. The function of these vesicles was not known.
Recently, Sacharidou et al. [73] described vacuoles, i.e. intracellular microparticle-like organelles in
the context of lumen formation of human umbilical vein endothelial cells. Endothelial vacuoles undergo
both intracellular fusion and exocytic fusion events with plasma membranes. Moreover, other intracel-
lular organelles, such as Weibel-Palade bodies, appear to fuse with intracellular vacuoles and transfer
their contents in order to rapidly create fluid-filled apical membranes and form early luminal structures.
Davis et al. [26] also described intracellular vacuoles targeting the apical surface, which are involved
in polarization of the endothelial cells during lumen formation. In the equine cultures established here,
microparticles were released from endothelial cells at the time of their integration from the monolayer
into the three-dimensional capillary-like structures. This step is related to an apparent change in the mor-
phology of endothelial cells and indicates a novel functional role within the cellular network. Moreover,
Shai and Varon [76] describe in their recent review that microparticles had been considered inert cell
debris, but increasing evidence suggests that they are involved in intercellular communication, including
angiogenesis. Correspondingly, microparticles of equine cultures may adopt various functions during the
phases of angiogenesis. However, their exact role still has to be clarified.
In conclusion, the assay presented here can be used as a model to monitor the steps of angiogenesis
starting from endothelial cell proliferation to the formation of a three-dimensional capillary-like structure.
Moreover, this assay allows for in vitro studies of endothelial pathophysiology, particularly the reaction of
endothelial cells to mechanical or chemical interventions. It is widely accepted that equine vessels are more
sensitive to manipulation as compared to those of other species, which often results in thrombophlebitis
or loss of function [30, 36, 52]. Future studies will target effects of mechanical or chemical lesions on
the equine angiogenic cascade in vitro with emphasis on microparticles and the specific population of tip
cells described above which we suspect to malfunction during thrombolysis.
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